Vice-Provost (Academic Affairs) Dr. Lynne-Marie Postovit

Dr. Lynne-Marie Postovit

In her role as Vice-Provost (Academic Affairs), Dr. Lynne-Marie Postovit leads the academic development of the university – this includes oversight of all academic appointments and renewal, tenure, and promotion processes, with a specific eye to research standards, and equity, diversity, and inclusion; disciplinary issues and collective bargaining, in collaboration with Faculty Relations; and leadership on capital projects with academic and/or university-wide implications.

Dr. Postovit is a highly respected researcher and recognized authority on ovarian cancer. She was most recently head of the Department of Biomedical and Molecular Sciences at ÷ÈÓ°Ö±²¥, and she has received numerous awards and distinctions, most recently a Canada Research Chair in Translational Cancer Research. Dr. Postovit earned her PhD in anatomy and cell biology at Queen’s, and before returning to the university as a professor in 2019, she held various positions at Western University and the University of Alberta, and co-directed the Cancer Research Institute of Northern Alberta.

Gazette News

Honorary degree recipients

Oct 27, 2025

Queen’s gets ready to celebrate fall convocation

Nine ceremonies held in Grant Hall November 3-7 will recognize the accomplishments of Queen’s graduates and two honorary degree recipients.

Teaching awards reception

Oct 24, 2025

Excellence in teaching, commitment to learning

New Principal’s Teaching and Learning Grants program launched at the annual university-wide teaching awards reception celebrating remarkable educators and staff.

Collage of Queen's Canada Research Chairs

Oct 22, 2025

Queen’s welcomes five new Canada Research Chairs

In addition to the new positions, three current chairs have been renewed. Announcement also included new research support funding.

÷ÈÓ°Ö±²¥ Logo on a blue field

Oct 21, 2025

÷ÈÓ°Ö±²¥ remembers Philip Osanic

The assistant professor and Queen’s Law alumnus had been teaching at the university for 22 years.